2026
Journal - Research Article
Watson, L. E., Annandale, M., MacRae, C. L., Bai, J., Dayaram, J., Burgess, N., … Fleming, N., … Mellor, K. M. (2026). An IL6 variant -174 G-C alters cardiac hypertrophy but not cardiometabolic responses to HFD in mice. npj Metabolic Health & Disease, 4(1), 13. doi: 10.1038/s44324-026-00107-3
2025
Journal - Research Article
Watson, L. E., MacRae, C. L., Kallingappa, P., Cao, Y., Li, X., Hedges, C. P., … Fleming, N., … Merry, T. L. (2025). An IL-6 promoter variant (-174 G/C) augments IL-6 production and alters skeletal muscle transcription in response to exercise in mice. Journal of Applied Physiology, 138, 213-225. doi: 10.1152/japplphysiol.00391.2024
Journal - Research Other
van der Werf, J., & Fleming, N. I. (2025). Are single nucleotide polymorphisms underutilized for guiding treatment of inflammatory bowel disease? Immunology & Cell Biology. Advance online publication. doi: 10.1111/imcb.70029
2024
Conference Contribution - Poster Presentation (not in published proceedings)
Watson, L. E., Annandale, M., MacRae, C., Fleming, N., Hedges, C. P., D'Souza, R. F., … Merry, T. L. (2024, August-September). Differential effects of an interleukin-6 promoter variant (-174 G>C) on acute exercise response and cardiometabolic disease in female and male mice. Poster session presented at the 18th New Zealand Medical Sciences Congress (MedSci), Queenstown, New Zealand.
Conference Contribution - Verbal presentation and other Conference outputs
van der Werf, J., Chin, C. V., Schultz, M., Dunbier, A., & Fleming, N. (2024, August-September). Influence of SNP rs1800795 on macrophage polarisation, colitis, and response to emerging therapies. Verbal presentation at the Queenstown Research Week (QRW) Cancer Meeting, Queenstown, New Zealand.
2023
Conference Contribution - Published proceedings: Abstract
van der Werf, J., Chin, C. V., Dunbier, A., & Fleming, N. (2023). Influence of SNP rs1800795 on macrophage polarisation, colitis, and response to emerging therapies. Proceedings of the Graduate Research Student Symposium. (pp. 26). Retrieved from https://www.otago.ac.nz/graduate-research
van der Werf, J., Chin, C. V., Dunbier, A., & Fleming, N. (2023). Influence of SNP rs1800795 on macrophage polarisation, colitis, and response to emerging therapies. Proceedings of the Genetics Otago (GO) Annual Symposium & Workshops. Retrieved from https://blogs.otago.ac.nz/go
Conference Contribution - Edited volume of conference proceedings
Milne, T., Anwar, M., Burga, L., Harcombe, H., Garelja, M., Middleton, A., Ribeiro, D. C., Fleming, N., Ogbuehi, K., & Bahn, A. (Eds.). (2023). Proceedings of the 268th Otago Medical School Research Society (OMSRS) Meeting: Masters/Honours/Postgraduate Diploma Student Speaker Awards. Dunedin, New Zealand: OMSRS. Retrieved from https://ourarchive.otago.ac.nz/handle/10523/12839
Milne, T., Anwar, M., Burga, L., Harcombe, H., Garelja, M., Middleton, A., Ribeiro, D. C., Fleming, N., Ogbuehi, K., & Bahn, A. (Eds.). (2023). Proceedings of the 267th Otago Medical School Research Society (OMSRS) Meeting: PhD Student Speaker Speaker Awards. Dunedin, New Zealand: OMSRS. Retrieved from https://ourarchive.otago.ac.nz/handle/10523/12839
Milne, T., Anwar, M., Burga, L., Harcombe, H., Garelja, M., Middleton, A., Ribeiro, D. C., Fleming, N., Ogbuehi, K., & Bahn, A. (Eds.). (2023). Proceedings of the 266th Otago Medical School Research Society (OMSRS) Meeting: Research Staff Speaker Awards. Dunedin, New Zealand: OMSRS. Retrieved from https://ourarchive.otago.ac.nz/handle/10523/12839
Milne, T., Anwar, M., Burga, L., Harcombe, H., Garelja, M., Middleton, A., Ribeiro, D. C., Fleming, N., Ogbuehi, K., & Bahn, A. (Eds.). (2023). Proceedings of the 265th Otago Medical School Research Society (OMSRS) Meeting: Summer Student Speaker Awards. Dunedin, New Zealand: OMSRS. Retrieved from https://ourarchive.otago.ac.nz/handle/10523/12839
Conference Contribution - Verbal presentation and other Conference outputs
Watson, L., MacRae, C., Fleming, N., D'Souza, R., Mellor, K., & Merry, T. (2023, August). An interlukin-6 promoter variant (-174 G>C) alters exercise-related gene transcriptional responses to exercise in mouse skeletal muscle. Verbal presentation at the 17th New Zealand Medical Sciences Congress (MedSci), Queenstown, New Zealand.
2022
Conference Contribution - Published proceedings: Abstract
Chin, A. C. V., van der Werf, J., Kallingappa, P., Brink, R., Merry, T. L., & Fleming, N. I. (2022). Successful modelling of a single nucleotide polymorphism in cells and mice using CRISPR-Cas9 and CRISPR-Cas12 methodologies. Proceedings of the Genetics Otago (GO) Annual Symposium. Retrieved from https://blogs.otago.ac.nz/go
Conference Contribution - Verbal presentation and other Conference outputs
Chin, A. C. V., van der Werf, J., Merry, T. L., & Fleming, N. I. (2022, August). Altered control of interleukin-6 during macrophage polarisation may contribute to colorectal cancer progression. Verbal presentation at the Cancer Satellite Meeting: Queenstown Research Week, Queenstown, New Zealand.
Watson, L., MacRae, C., Kallingappa, P., Fleming, N. I., & Merry, T. L. (2022, August). The paradoxical role of IL-6 in cardiometabolic health. Verbal presentation at the Metabolic & Cardiovascular Disease Satellite Meeting: Queenstown Research Week, Queenstown, New Zealand.
Chin, A. C. V., van der Werf, J., Kallingappa, P., Brink, R., Merry, T. L., & Fleming, N. I. (2022, August). Successful modelling of a single nucleotide polymorphism in cells and mice using CRISPR-Cas9 and CRISPR-Cas12 methodologies. Verbal presentation at the CRISPR Technologies Satellite Meeting: Queenstown Research Week, Queenstown, New Zealand.
Watson, L. E., MacRae, C., Fleming, N., D'Souza, R. F., & Merry, T. L. (2022, August-September). Understanding the role of the IL-6 -174 G/C (rs1800795) promoter variant in metabolic responses to exercise. Verbal presentation at the 16th New Zealand Medical Sciences Congress (MedSci), Queenstown, New Zealand.
2021
Journal - Research Other
van der Werf, J., Chin, C. V., & Fleming, N. I. (2021). SnoRNA in cancer progression, metastasis and immunotherapy response. Biology, 10, 809. doi: 10.3390/biology10080809
2020
Journal - Research Article
Eiholzer, R. A., Mehta, S., Kazantseva, M., Drummond, C. J., McKinney, C., Young, K., … Fleming, N., Morrin, H. R., Reader, K., Royds, J. A., Landmann, M., Petrich, S., … Taha, A., Hung, N. A., Slatter, T. L., & Braithwaite, A. W. (2020). Intronic TP53 polymorphisms are associated with increased Δ133TP53 transcript, immune infiltration and cancer risk. Cancers, 12(9), 2472. doi: 10.3390/cancers12092472
2018
Journal - Research Article
Campbell, H., Fleming, N., Roth, I., Mehta, S., Wiles, A., Williams, G., … Munro, F., McNoe, L., Black, M., McCall, J., Slatter, T. L., … Braithwaite, A. W. (2018). Δ133p53 isoform promotes tumour invasion and metastasis via interleukin-6 activation of JAK-STAT and RhoA-ROCK signalling. Nature Communications, 9(1), 254. doi: 10.1038/s41467-017-02408-0
Conference Contribution - Published proceedings: Abstract
Munro, F., Gimenez, G., Shepherd, P., Braithwaite, A., McCall, J., & Fleming, N. (2018). A common variation in the IL6 promoter predicts time to metastasis for colorectal cancer and may indicate the mechanisms involved. Proceedings of the New Zealand Society for Oncology (NZSO) Conference. Retrieved from http://www.nzsoncology.org.nz/
Conference Contribution - Poster Presentation (not in published proceedings)
Henderson, L., Mehta, S., Fleming, N., Eccles, M., Chatterjee, A., Print, C., … Braithwaite, A. (2018, August). p63 promotes proliferation in melanoma cell lines via regulation of AQP3. Poster session presented at the Queenstown Molecular Biology (QMB) Meetings, Queenstown, New Zealand.
Conference Contribution - Verbal presentation and other Conference outputs
Munro, F. M., Gimenez, G., Shepherd, P. R., Braithwaite, A. W., McCall, J. L., & Fleming, N. I. (2018, August). Regulation of IL-6 is pivotal to outcome in colorectal cancer. Verbal presentation at the Queenstown Molecular Biology (QMB) Meetings, Queenstown, New Zealand.
2016
Journal - Research Article
Slatter, T. L., Wilson, M., Tang, C., Campbell, H. G., Ward, V. K., Young, V. L., … Fleming, N. I., Braithwaite, A. W., & Baird, M. A. (2016). Antitumor cytotoxicity induced by bone-marrow-derived antigen-presenting cells is facilitated by the tumor suppressor protein p53 via regulation of IL-12. OncoImmunology, 5(3), e1112941. doi: 10.1080/2162402X.2015.1112941
Roth, I., Campbell, H., Rubio, C., Vennin, C., Wilson, M., Wiles, A., Williams, G., Woolley, A., … Fleming, N., Baird, M., & Braithwaite, A. W. (2016). The Δ133p53 isoform and its mouse analogue Δ122p53 promote invasion and metastasis involving pro-inflammatory molecules interleukin-6 and CCL2. Oncogene, 35, 4981-4989. doi: 10.1038/onc.2016.45
Conference Contribution - Verbal presentation and other Conference outputs
Fleming, N. (2016, March). Control of the IL6 by the p53 protein family. Verbal presentation at the Genetics Otago Symposium, Dunedin, New Zealand.
Fleming, N. I., Henderson, L. E., Campbell, H. G., Antony, J., Print, C. G., Baird, M., & Braithwaite, A. W. (2016, August-September). A common variation within the IL6 promoter may alter its control by the p53 protein family and influence cancer progression. Verbal presentation at the Queenstown Molecular Biology (QMB) Meetings, Nelson, New Zealand.
Mehta, S., Lasham, A., Woolley, A., Algie, M., Al Jabry, T., Ma, W., Fleming, N., Young, K., Parker, K., … Braithwaite, A. (2016, August-September). Role of YB-1 in cell cycle. Verbal presentation at the Queenstown Molecular Biology (QMB) Meetings, Nelson, New Zealand.
Campbell, H., Fleming, N., Roth, I., Vennin, C., McCall, J., Mehta, S., Wiles, A., Williams, G., … Baird, M., & Braithwaite, A. W. (2016, August-September). IL-6 signalling mediates tumorigenesis, invasion and metastasis driven by the Δ133p53 isoform. Verbal presentation at the Queenstown Molecular Biology (QMB) Meetings, Nelson, New Zealand.
2015
Conference Contribution - Poster Presentation (not in published proceedings)
Roth, I., Campbell, H., Rubio, C., Vennin, C., Wilson, M., Wiles, A., Williams, G., … Fleming, N., Baird, M., & Braithwaite, A. (2015, October). Does a variant of the tumour suppressor P53 play a role in tumour metastasis? Poster session presented at the Otago Spotlight Series: Cancer Research, Wellington, New Zealand.
Conference Contribution - Verbal presentation and other Conference outputs
Fleming, N., Henderson, L. E., Print, C. G., Baird, M. A., & Braithwaite, A. W. (2015, August). Tumour suppression mechanisms and pro-migratory signals. Verbal presentation at the Queenstown Molecular Biology (QMB) Meetings, Queenstown, New Zealand.
2014
Journal - Research Article
Diesch, J., Sanij, E., Gilan, O., Love, C., Tran, H., Fleming, N. I., … Dhillon, A. S. (2014). Widespread FRA1-dependent control of mesenchymal transdifferentiation programs in colorectal cancer cells. PLoS ONE, 9(3), e88950. doi: 10.1371/journal.pone.0088950
Shalev, I., Moffitt, T. E., Braithwaite, A. W., Danese, A., Fleming, N. I., Goldman-Mellor, S., … Poulton, R., Robertson, S. P., … Caspi, A. (2014). Internalizing disorders and leukocyte telomere erosion: A prospective study of depression, generalized anxiety disorder and post-traumatic stress disorder. Molecular Psychiatry, 19, 1163-1170. doi: 10.1038/mp.2013.183
Conference Contribution - Poster Presentation (not in published proceedings)
Roth, I., Rubio, C., Campbell, H., Fleming, N., Baird, M., & Braithwaite, A. (2014, September). The Δ133p53 isoform promotes secreted cytokine-dependent cell migration. Poster session presented at the Division of Health Sciences Research Forum: Learning Different Research Languages, Dunedin, New Zealand.
2013
Journal - Research Article
Fleming, N. I., Jorissen, R. N., Mouradov, D., Christie, M., Sakthianandeswaren, A., Palmieri, M., … Sieber, O. M. (2013). SMAD2, SMAD3 and SMAD4 mutations in colorectal cancer. Cancer Research, 73(2), 725-735. doi: 10.1158/0008-5472.CAN-12-2706
2011
Journal - Research Article
Sakthianandeswaren, A., Christie, M., D'Andreti, C., Tsui, C., Jorissen, R. N., Li, S., Fleming, N. I., … Sieber, O. M. (2011). PHLDA1 expression marks the putative epithelial stem cells and contributes to intestinal tumorigenesis. Cancer Research, 71(10), 3709-3719. doi: 10.1158/0008-5472.CAN-10-2342
2010
Journal - Research Article
Fleming, N. I., Knower, K. C., Lazarus, K. A., Fuller, P. J., Simpson, E. R., & Clyne, C. D. (2010). Aromatase is a direct target of FOXL2: C134W in granulosa cell tumors via a single highly conserved binding site in the ovarian specific promoter. PLoS ONE, 5(12), e14389. doi: 10.1371/journal.pone.0014389
2009
Journal - Research Article
Fleming, N. I., Trivett, M. K., George, J., Slavin, J. L., Murray, W. K., Moseley, J. M., … Thomas, D. M. (2009). Parathyroid hormone—related protein protects against mammary tumor emergence and is associated with monocyte infiltration in ductal carcinoma in situ. Cancer Research, 69(18), 7473-7479. doi: 10.1158/0008-5472.CAN-09-0194
2004
Journal - Research Article
Thomas, D. M., Fleming, N. I., Holloway, A. J., & Bowtell, D. D. L. (2004). Molecular medicine: A clinician's primer on microarrays. Internal Medicine Journal, 34(9-10), 565-569. doi: 10.1111/j.1445-5994.2004.00680.x
2003
Journal - Research Article
Gill, H., Cheadle, J. P., Maynard, J., Fleming, N., Whatley, S., Cranston, T., … Clarke, A. (2003). Mutation analysis in the MECP2 gene and genetic counselling for Rett syndrome. Journal of Medical Genetics, 40(5), 380-384. doi: 10.1136/jmg.40.5.380
2002
Journal - Research Article
Cheadle, J. P., Krawczak, M., Thomas, M. W., Hodges, A. K., Al-Tassan, N., Fleming, N., & Sampson, J. R. (2002). Different combinations of biallelic APC mutation confer different growth advantages in colorectal tumours. Cancer Research, 62(2), 363-366.
Al-Tassan, N., Chmiel, N. H., Maynard, J., Fleming, N., Livingston, A. L., Williams, G. T., … Cheadle, J. P. (2002). Inherited variants of MYH associated with somatic G:C→T:A mutations in colorectal tumors. Nature Genetics, 30(2), 227-232. doi: 10.1038/ng828
2001
Journal - Research Article
Fleming, N., Maynard, J., Tzitzis, L., Sampson, J. R., & Cheadle, J. P. (2001). LD-PCR coupled to long-read direct sequencing: An approach for mutation detection in genes with compact genomic structures. Journal of Biochemical & Biophysical Methods, 47(1-2), 131-136.
2000
Journal - Research Article
Cheadle, J. P., Gill, H., Fleming, N., Maynard, J., Kerr, A., Leonard, H., … Clarke, A. (2000). Long-read sequence analysis of the MECP2 gene in Rett syndrome patients: Correlation of disease severity with mutation type and location. Human Molecular Genetics, 9(7), 1119-1129.
